N-acetylglucosamine-6-sulfatase: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
CSV import
 
Line 24: Line 24:
{{medicine-stub}}
{{medicine-stub}}
{{No image}}
{{No image}}
__NOINDEX__

Latest revision as of 19:34, 17 March 2025

N-acetylglucosamine-6-sulfatase (G6S) is an enzyme that is involved in the degradation of glycosaminoglycans in the body. This enzyme is encoded by the G6S gene in humans.

Function[edit]

N-acetylglucosamine-6-sulfatase is a lysosomal enzyme that catalyzes the removal of 6-sulfate groups from the N-acetyl-D-glucosamine 6-sulfate units of keratan sulfate and chondroitin sulfate. The enzyme is a member of the sulfatase family, which is a group of enzymes that catalyze the hydrolysis of sulfuric acid esters.

Clinical significance[edit]

Deficiency of N-acetylglucosamine-6-sulfatase leads to the lysosomal storage disorder Mucopolysaccharidosis type IIID (MPS IIID), also known as Sanfilippo syndrome type D. This is a rare and severe neurodegenerative disorder characterized by progressive mental and motor deterioration, leading to severe disability and death in early adulthood.

Structure[edit]

The G6S gene is located on the long arm of chromosome 12 (12q14) and spans approximately 40 kilobases. The gene encodes a protein of 552 amino acids with a calculated molecular mass of 63 kDa.

See also[edit]

References[edit]

<references />

Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!